"Mast-Cell Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Descriptor ID |
D012515
|
| MeSH Number(s) |
C04.557.450.565.465.124
|
| Concept/Terms |
Mast-Cell Sarcoma- Mast-Cell Sarcoma
- Mast Cell Sarcoma
- Mastocytoma, Malignant
- Malignant Mastocytoma
- Malignant Mastocytomas
- Mastocytomas, Malignant
- Sarcoma, Mast-Cell
- Mast-Cell Sarcomas
- Sarcoma, Mast Cell
- Sarcomas, Mast-Cell
|
Below are MeSH descriptors whose meaning is more general than "Mast-Cell Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Mast-Cell Sarcoma".
This graph shows the total number of publications written about "Mast-Cell Sarcoma" by people in this website by year, and whether "Mast-Cell Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mast-Cell Sarcoma" by people in Profiles.
-
Wei C, Storozynsky E, McAdam AJ, Yeh KY, Tilton BR, Willis RA, Barth RK, Looney RJ, Lord EM, Frelinger JG. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 1996 Jul; 42(6):362-8.
-
Kapur R, Evans DL, Harris DT. An evolutionary conserved target cell antigen along with MHC class I molecules influences susceptibility to murine NK cell lysis. Dev Comp Immunol. 1995 Jul-Aug; 19(4):347-55.
-
Harris DT, Sekaly RP. Target cell susceptibility to immune lysis and expression of MHC antigens are independent of position in the cell cycle. J Immunol. 1984 Jul; 133(1):40-4.
-
Asbell SO, Gadol N, Saluk P, Vonderheid EC, Brady LW. Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and S?zary syndrome. Int J Radiat Oncol Biol Phys. 1978 Jul-Aug; 4(7-8):609-13.